Evaluation of Diasorin Liaison® calprotectin fecal assay adapted for pleural effusion

被引:0
|
作者
Poves, Cristina de Paz [5 ]
Barneo-Caragol, Clara [1 ]
Sanchez, Ana Isabel Cillero [2 ]
Mendiguchia, Lucia Jimenez [3 ]
Caso, Covadonga Quiros [1 ]
Rodriguez, Maria Moreno [3 ]
Gonzalez, Francisco J. Lopez [4 ]
Garcia, Ma Belen Prieto [1 ]
机构
[1] Hosp Univ Cent Asturias, Dept Clin Biochem, Lab Med, Oviedo, Asturias, Spain
[2] Hosp Alvarez Buylla, Dept Clin Biochem, Mieres, Asturias, Spain
[3] Hosp Univ San Agustin, Dept Clin Biochem, Aviles, Asturias, Spain
[4] Hosp Univ Cent Asturias, Dept Pneumol, Oviedo, Asturias, Spain
[5] Hosp Univ Cent Asturias, Dept Clin Biochem, Lab Med, Ave Roma S-N, Oviedo 33011, Asturias, Spain
关键词
automation; calprotectin; chemiluminescence; pleural fluid; validation; MARKER;
D O I
10.1515/almed-2023-0106
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Calprotectin (CP) is a calcium and zinc binding protein that is widely measured on faecal samples but its determination in other biological fluids might be of interest. The aim of this work was to validate the measurement of CP in pleural fluid by chemiluminescence.Methods: LIAISON (R) XL, a fully automated chemiluminescence analyzer, was used for CP quantification on pleural fluid. A validation protocol was designed using both quality control materials provided by the manufacturer and pools of pleural fluid samples. Stability, imprecision, bias, linearity, detection capability and carry over effect were evaluated.Results: CP was stable on pleural fluid at least one week, under refrigerated conditions, and four weeks at -80 80 degrees C. The observed intra- and inter-day imprecision was between 2.2 and 6.49 %, with a negative bias under 5.51 %. The linearity of the method was verified up to 2,000 ng/mL. The LoQ for the assay was 48.52 ng/mL. A statistically significant carry-over effect was observed after measuring CP concentrations above the upper limit of linearity, but given the observed magnitude, a clinically relevant impact should not be expected.Conclusions: Diasorin Liaison (R) calprotectin assay allows reliable measurement of CP in pleural fluid.
引用
收藏
页码:419 / 424
页数:6
相关论文
共 50 条
  • [21] The fully-automated LIAISON Calprotectin immunoassay from DiaSorin can distinguish between IBD and IBS patients
    Steijn, R. Vicente
    Jansen, J. M.
    Bisheshar, R.
    Romeijn, M.
    Haagen, I. -A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S149 - S149
  • [22] CLINICAL PERFORMANCE OF AN IMMUNOTURBIDIMETRIC ASSAY FOR DETECTING FECAL CALPROTECTIN
    Wang, Tieshan
    Han, Muzhou
    Fan, Liqiaona
    Zhu, Siying
    Li, Peng
    Zhang, Shutian
    Shi, Haiyun
    GUT, 2022, 71 : A156 - A157
  • [23] Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
    Omar M. Mohammed
    Kamel M. Hussein
    Abdelgawad E. Ramadan
    Gouda T. Mahmoud
    Marwa El-Sayed El-Naggar
    Nor Eldein Z. Gaber
    Egyptian Journal of Bronchology, 2019, 13 : 382 - 387
  • [24] Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
    Maribel Botana-Rial
    Lorena Vázquez-Iglesias
    Pedro Casado-Rey
    María Páez de la Cadena
    María Amalia Andrade-Olivié
    José Abal-Arca
    Laura García-Nimo
    Lucía Ferreiro-Fernández
    Luis Valdés-Cuadrado
    María Esther San-José
    Francisco Javier Rodríguez-Berrocal
    Alberto Fernández-Villar
    Scientific Reports, 10
  • [25] Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
    Mohammed, Omar M.
    Hussein, Kamel M.
    Ramadan, Abdelgawad E.
    Mahmoud, Gouda T.
    El-Naggar, Marwa El-Sayed
    Gaber, Nor Eldein Z.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2019, 13 (03) : 382 - 387
  • [26] Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
    Botana-Rial, Maribel
    Vazquez-Iglesias, Lorena
    Casado-Rey, Pedro
    Paez de la Cadena, Maria
    Amalia Andrade-Olivie, Maria
    Abal-Arca, Jose
    Garcia-Nimo, Laura
    Ferreiro-Fernandez, Lucia
    Valdes-Cuadrado, Luis
    Esther San-Jose, Maria
    Javier Rodriguez-Berrocal, Francisco
    Fernandez-Villar, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Diagnostic evaluation of pleural effusion
    Porcel, JM
    Caballero, MR
    MEDICINA CLINICA, 2004, 123 (11): : 426 - 432
  • [28] Evaluation of the patient with pleural effusion
    Beaudoin, Stephane
    Gonzalez, Anne V.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (10) : E291 - E295
  • [29] DIAGNOSTIC EVALUATION OF PLEURAL EFFUSION
    CHANDRASEKHAR, AJ
    BUEHLER, JH
    GERIATRICS, 1974, 29 (07) : 116 - +
  • [30] PLEURAL EFFUSION - DIAGNOSTIC EVALUATION
    MENA, G
    REVISTA MEDICA DE CHILE, 1983, 111 (01) : 78 - 82